Research that Identifies
Undiscovered Value in the MicroCap Market


Trxade Health Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, SEC Filings, Bloomberg

Report Link: Updated Research Report (Dated 05/03/2021)

Symbol: MEDS
Analyst: Howard Halpern
Taglich Rating: Speculative Buy
Price Target: $7.25
Time Horizon: 12 Months
Rating Established: June 10, 2020
Price When Established: $6.12
Most Recent Report: May 3, 2021
Price When Issued: $4.35

What's New

TRxADE Group Announces Name Change

On May 28, 2021, Trxade Group, Inc. announced that effective June 1, 2021 that its name will change to TRxADE HEALTH Inc. The company’s trading symbol will remain MEDS.

The name change is being made to better reflect the company’s portfolio of offerings as a health services information technology (IT) company that is focused on digitalizing the retail pharmacy experience.

Company Description

Trxade Health, Inc., headquartered in Tampa, Florida, is an integrated technology and services company focused on delivering an effective process for purchasing and delivering prescription drugs to independent pharmacies and consumers in the US. MEDS is developing a complete platform to make healthcare services affordable and accessible in the US through the integration of its existing Web-based trading platform, a licensed wholesaler, and its mobile telehealth service through the Bonum Health app and delivery capabilities. The company is developing the ability to provide healthcare services to patients without the patient leaving their home.

Company Reports

Updated Research Report (Dated 05/03/2021)
Updated Research Report (Dated 04/05/2021)
Updated Research Report (Dated 11/02/2020)
Updated Research Report (Dated 07/30/2020)
Initial Research Report (Dated 06/10/2020)


Please view our current disclosure and disclaimer on our most recent research report.